Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro

Noel R. Rose, Judith A. Haber, Paul Calabresi

Research output: Contribution to journalArticle

Abstract

Actinomycin D, puromycin, 6-mercaptopurine, and cytosine arabinoside were shown to decrease the number of plaque-forming units upon in vitro incubation with suspensions of spleen cells taken from sheep-cell immunized mice. Under similar conditions, 5-iodo-2′-deoxyuridine, 5-bromo-2′-deoxyuridine, azauridine, and chloramphenicol had no effect. Administered in vivo, 6-mercaptopurine, cytosine arabinoside, and chloramphenicol all suppressed plaque production. In the case of the latter two antimetabolites, serum antibody titers remained unaffected by the dosages given.

Original languageEnglish (US)
Pages (from-to)1121-1128
Number of pages8
JournalProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)
Volume128
Issue number4
DOIs
StatePublished - Sep 8 1968
Externally publishedYes

Fingerprint

6-Mercaptopurine
Cytarabine
Chloramphenicol
Immunosuppressive Agents
Azauridine
Antimetabolites
Puromycin
Deoxyuridine
Dactinomycin
Bromodeoxyuridine
Sheep
Suspensions
Spleen
Antibodies
Serum
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro. / Rose, Noel R.; Haber, Judith A.; Calabresi, Paul.

In: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.), Vol. 128, No. 4, 08.09.1968, p. 1121-1128.

Research output: Contribution to journalArticle

@article{d33bb912a8574a508b3b2db6e9b06098,
title = "Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro",
abstract = "Actinomycin D, puromycin, 6-mercaptopurine, and cytosine arabinoside were shown to decrease the number of plaque-forming units upon in vitro incubation with suspensions of spleen cells taken from sheep-cell immunized mice. Under similar conditions, 5-iodo-2′-deoxyuridine, 5-bromo-2′-deoxyuridine, azauridine, and chloramphenicol had no effect. Administered in vivo, 6-mercaptopurine, cytosine arabinoside, and chloramphenicol all suppressed plaque production. In the case of the latter two antimetabolites, serum antibody titers remained unaffected by the dosages given.",
author = "Rose, {Noel R.} and Haber, {Judith A.} and Paul Calabresi",
year = "1968",
month = "9",
day = "8",
doi = "10.3181/00379727-128-33210",
language = "English (US)",
volume = "128",
pages = "1121--1128",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "0037-9727",
publisher = "Society for Experimental Biology and Medicine",
number = "4",

}

TY - JOUR

T1 - Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro

AU - Rose, Noel R.

AU - Haber, Judith A.

AU - Calabresi, Paul

PY - 1968/9/8

Y1 - 1968/9/8

N2 - Actinomycin D, puromycin, 6-mercaptopurine, and cytosine arabinoside were shown to decrease the number of plaque-forming units upon in vitro incubation with suspensions of spleen cells taken from sheep-cell immunized mice. Under similar conditions, 5-iodo-2′-deoxyuridine, 5-bromo-2′-deoxyuridine, azauridine, and chloramphenicol had no effect. Administered in vivo, 6-mercaptopurine, cytosine arabinoside, and chloramphenicol all suppressed plaque production. In the case of the latter two antimetabolites, serum antibody titers remained unaffected by the dosages given.

AB - Actinomycin D, puromycin, 6-mercaptopurine, and cytosine arabinoside were shown to decrease the number of plaque-forming units upon in vitro incubation with suspensions of spleen cells taken from sheep-cell immunized mice. Under similar conditions, 5-iodo-2′-deoxyuridine, 5-bromo-2′-deoxyuridine, azauridine, and chloramphenicol had no effect. Administered in vivo, 6-mercaptopurine, cytosine arabinoside, and chloramphenicol all suppressed plaque production. In the case of the latter two antimetabolites, serum antibody titers remained unaffected by the dosages given.

UR - http://www.scopus.com/inward/record.url?scp=84912287139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912287139&partnerID=8YFLogxK

U2 - 10.3181/00379727-128-33210

DO - 10.3181/00379727-128-33210

M3 - Article

AN - SCOPUS:84912287139

VL - 128

SP - 1121

EP - 1128

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 0037-9727

IS - 4

ER -